Market Closed -
London S.E.
11:35:25 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
91.85
GBX
|
+0.93%
|
|
0.00%
|
-11.51%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,946
|
2,010
|
2,018
|
1,481
|
1,387
|
1,227
|
-
|
-
|
Enterprise Value (EV)
1 |
3,071
|
3,124
|
3,260
|
2,751
|
1,387
|
2,575
|
2,639
|
2,709
|
P/E ratio
|
-24.6
x
|
17.6
x
|
15.4
x
|
50.4
x
|
51.9
x
|
12.2
x
|
8.09
x
|
5.96
x
|
Yield
|
3.5%
|
3.86%
|
4.1%
|
5.87%
|
-
|
7.48%
|
7.6%
|
7.62%
|
Capitalization / Revenue
|
16.8
x
|
15.3
x
|
14.8
x
|
10.5
x
|
9.29
x
|
8
x
|
7.75
x
|
7.48
x
|
EV / Revenue
|
26.5
x
|
23.8
x
|
23.8
x
|
19.4
x
|
9.29
x
|
16.8
x
|
16.7
x
|
16.5
x
|
EV / EBITDA
|
29.7
x
|
26.5
x
|
25.8
x
|
20.9
x
|
9.99
x
|
18.3
x
|
18.1
x
|
18.1
x
|
EV / FCF
|
80.4
x
|
194
x
|
302
x
|
64.3
x
|
-
|
-1,144
x
|
-22.8
x
|
-
|
FCF Yield
|
1.24%
|
0.52%
|
0.33%
|
1.56%
|
-
|
-0.09%
|
-4.39%
|
-
|
Price to Book
|
-
|
1.42
x
|
1.35
x
|
1
x
|
-
|
0.98
x
|
0.92
x
|
0.87
x
|
Nbr of stocks (in thousands)
|
1,216,322
|
1,315,551
|
1,332,888
|
1,336,494
|
1,335,965
|
1,335,564
|
-
|
-
|
Reference price
2 |
1.600
|
1.528
|
1.514
|
1.108
|
1.038
|
0.9185
|
0.9185
|
0.9185
|
Announcement Date
|
2/12/20
|
2/18/21
|
2/16/22
|
2/22/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
115.7
|
131.2
|
136.7
|
141.5
|
149.3
|
153.4
|
158.3
|
164
|
EBITDA
1 |
103.4
|
118
|
126.2
|
131.9
|
138.8
|
141
|
145.5
|
149.6
|
EBIT
1 |
103.4
|
118
|
126.2
|
131.9
|
138.8
|
141.8
|
145.1
|
147.8
|
Operating Margin
|
89.37%
|
89.94%
|
92.32%
|
93.22%
|
92.97%
|
92.39%
|
91.65%
|
90.11%
|
Earnings before Tax (EBT)
1 |
-70.2
|
112.4
|
141.6
|
56.9
|
26.1
|
109
|
161.2
|
200.7
|
Net income
1 |
-71.3
|
112
|
140.1
|
56.3
|
27.3
|
118
|
163.8
|
198.7
|
Net margin
|
-61.62%
|
85.37%
|
102.49%
|
39.79%
|
18.29%
|
76.93%
|
103.47%
|
121.16%
|
EPS
2 |
-0.0650
|
0.0870
|
0.0980
|
0.0220
|
0.0200
|
0.0753
|
0.1135
|
0.1540
|
Free Cash Flow
1 |
38.2
|
16.1
|
10.8
|
42.8
|
-
|
-2.25
|
-116
|
-
|
FCF margin
|
33.02%
|
12.27%
|
7.9%
|
30.25%
|
-
|
-1.47%
|
-73.26%
|
-
|
FCF Conversion (EBITDA)
|
36.94%
|
13.64%
|
8.56%
|
32.45%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
14.38%
|
7.71%
|
76.02%
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0560
|
0.0590
|
0.0620
|
0.0650
|
-
|
0.0687
|
0.0698
|
0.0700
|
Announcement Date
|
2/12/20
|
2/18/21
|
2/16/22
|
2/22/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2022 S1
|
---|
Net sales
|
-
|
-
|
EBITDA
|
-
|
-
|
EBIT
|
-
|
-
|
Operating Margin
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
Net income
|
-
|
-
|
Net margin
|
-
|
-
|
EPS
|
-
|
-
|
Dividend per Share
1 |
0.0295
|
0.0325
|
Announcement Date
|
7/29/20
|
7/27/22
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,125
|
1,114
|
1,242
|
1,270
|
-
|
1,348
|
1,413
|
1,482
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
10.88
x
|
9.44
x
|
9.84
x
|
9.631
x
|
-
|
9.56
x
|
9.708
x
|
9.906
x
|
Free Cash Flow
1 |
38.2
|
16.1
|
10.8
|
42.8
|
-
|
-2.25
|
-116
|
-
|
ROE (net income / shareholders' equity)
|
5.92%
|
5.53%
|
4.26%
|
3.78%
|
-
|
6.71%
|
6.81%
|
6.68%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
3.26%
|
3.28%
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
3,622
|
4,995
|
-
|
Book Value Per Share
2 |
-
|
1.080
|
1.130
|
1.110
|
-
|
0.9400
|
1.000
|
1.060
|
Cash Flow per Share
2 |
-
|
0.0900
|
0.1000
|
0.0800
|
-
|
0.0700
|
0.0700
|
0.0700
|
Capex
1 |
55.8
|
103
|
130
|
74.8
|
-
|
9.93
|
30
|
30
|
Capex / Sales
|
48.23%
|
78.35%
|
94.81%
|
52.86%
|
-
|
6.47%
|
18.95%
|
18.29%
|
Announcement Date
|
2/12/20
|
2/18/21
|
2/16/22
|
2/22/23
|
2/28/24
|
-
|
-
|
-
|
Last Close Price
0.9185
GBP Average target price
1.033
GBP Spread / Average Target +12.50% Consensus |
1st Jan change
|
Capi.
|
---|
| -11.51% | 1.53B | | +4.62% | 55.76B | | -11.72% | 17.72B | | -5.05% | 13.23B | | +1.40% | 7.68B | | -17.93% | 5.39B | | +8.62% | 3.28B | | -5.42% | 3.06B | | -8.15% | 2.73B | | +12.61% | 2.73B |
Healthcare REITs
|